Insurance by BogdanovaThe Encyclopedia of Insurance and Risk Science

RESEARCH DOSSIER

Long-Term Care Insurance Consumer Disclosure and Sales Suitability

Abstract. Long-term care insurance is sold as a promise about future access to financial protection in circumstances that may arise decades after purchase. Its consumer-protection problem is therefore intertemporal: a buyer must understand contractual eligibility, care settings, monetary limits, inflation adjustments, premium uncertainty, replacement consequences, and the possibility that coverage will become unaffordable precisely when the probability of needing care increases. This monograph investigates how disclosure and sales suitability can be evaluated across the policy life cycle, from initial illustration through premium revision, benefit reduction, claim, and lapse. It examines U.S. model and federal provisions, state-level supervisory instruments, European Union insurance-distribution requirements, U.K. conduct rules, and German supplementary care insurance, placing each rule within its own legal scope. It then critically synthesizes empirical evidence about information frictions, family-care expectations, private information, and insurer credibility. Original analysis compares the informational content of contract documents and benefit illustrations with the decision actually faced by a consumer; demonstrates the erosion of nominal daily benefits under explicitly hypothetical care-cost scenarios; examines how the policyholder's available options change at a rate increase; and sets out a replicable documentary and empirical audit of disclosure quality. The principal finding is that meaningful suitability is an ongoing, verifiable relationship between the proposed coverage, household financial capacity, expected care needs, and the consequences of future adjustments. Product information becomes substantively useful when it makes those consequences reconstructable, including which risks remain with the policyholder and which options preserve benefits. The work is a comparative analytical monograph. It advances no separately named theoretical system and makes no original population-level causal estimate.

Keywords: Long-term care insurance; insurance consumer protection; sales suitability; product disclosure; benefit illustration; inflation protection; activities of daily living; cognitive impairment; elimination period; reduced benefit options; premium rate increases; unintended lapse; nonforfeiture; insurance distribution; market conduct; informational frictions; international insurance regulation.

Introduction

A person may buy long-term care insurance while healthy and employed, fund it through many years of premium payments, and first seek benefits after retirement, cognitive decline, loss of mobility, or the absence of available family caregivers. Decisions made in the sales encounter therefore alter a future claim that the policyholder may be unable to administer personally. For the purchaser, the relevant promise is practical: some portion of future care costs will be funded under specified circumstances. The promise has several layers, and a financially impressive headline benefit may coexist with an elimination period, provider restrictions, reimbursement limits, a finite pool, and a contractually permitted classwide premium increase.

The U.S. Long-Term Care Insurance Model Act defines a broad family of long-duration care policies and riders. The corresponding Long-Term Care Insurance Model Regulation supplies unusually detailed templates for policy disclosure, benefit-trigger safeguards, suitability worksheets, replacement notices, and lapse protection. These texts establish a valuable comparative reference. They remain model instruments: the legal effect in a particular U.S. state depends on its enacted law, effective date, filing approvals, and actual policy form. Federal tax-qualified insurance provisions impose additional requirements, but tax qualification must never be confused with a guarantee that a policy fits a purchaser's circumstances.

The scientific question is broader than whether a page of contract wording is intelligible. It is whether information presented at a particular decision date permits a person to compare the actual outcomes of staying insured, switching insurers, reducing coverage, retaining current benefits at an increased premium, or surrendering protection. Consumer comprehension, legal disclosure, economic welfare, and insurer solvency interact, while remaining analytically distinct. A market may achieve formally complete disclosure and still exhibit weak understanding; it may also feature useful insurance for a limited subgroup without making the same product suitable for every household.

This study asks three linked questions. First, which contract provisions and primary legal sources define exclusions, benefit escalation, and sales disclosures? Second, how do product structure, household preferences, public programs, market incentives, and behavioral constraints affect understanding? Third, what observable market-conduct outcomes, including lapse and reduced benefits, can reasonably be attributed to sales practice rather than to financial or demographic selection?

The evidence base consists of primary regulatory and statutory materials, official consumer guidance, peer-reviewed research, one directly labeled industry survey, and a consumer-advocacy briefing identified as such. Legal comparison is jurisdiction-specific, and scientific claims are confined to the populations and research designs actually covered. The quantitative examples below are reproducible illustrations using declared assumptions, not insurer quotations or representative market premiums.

Historical Development, Concepts, and the Boundaries of Consumer Protection

From nursing-home indemnity to diversified care benefits

Early private long-term care products concentrated on institutional nursing-home expenditures. Subsequent contract generations expanded toward home care, assisted living, adult day services, and other community settings. The NAIC's long-term care market overview describes the movement from initially thin claims experience toward a market with a large legacy in-force block. Initially optimistic assumptions about benefit utilization, duration, lapse, and investment return contributed to material premium revisions. The distinction between the insurer's expectation at issue and the contractholder's later financial experience is central to this monograph.

A long-term care contract may pay reimbursed eligible expenses up to a ceiling; fixed indemnity or cash benefits may instead pay a defined amount after a valid trigger, regardless of an exactly matching invoice. A policy can have a daily or monthly maximum, aggregate lifetime amount, maximum benefit duration, waiting or elimination period, and a schedule of inflation increases. Riders can connect long-term care to life insurance or annuities. Consequently, there is no analytically valid comparison of two policy prices without matching benefits, triggers, benefit pools, care settings, insurer rights, and funding source. The NAIC shopper's guide expressly encourages prospective purchasers to record local care prices and compare policy specifications.

Long-term care need is a functional and care-related condition; disability income insurance is concerned principally with loss of earnings capacity under its contractual definitions. Acute medical insurance covers different events and services. In the United States, the official Medicare long-term-care coverage explanation states that custodial long-term care is generally outside Medicare benefits. Medicaid, by contrast, finances certain institutional services and home- and community-based programs for eligible beneficiaries. The federal 1915(c) waiver guidance makes clear that benefit design, eligibility, and capacity vary across states. Disclosure must therefore identify the actual public-program interaction rather than implying that ordinary health coverage automatically supplies personal care.

Functional eligibility and tax qualification

The U.S. Internal Revenue Code section 7702B uses specified chronic-illness certification conditions for qualified long-term care insurance. These include substantial assistance with at least two activities of daily living for a period expected to last at least 90 days or substantial supervision because of severe cognitive impairment, within the law's more detailed statutory conditions. The statute lists eating, toileting, transferring, bathing, dressing, and continence, and establishes requirements concerning certification and prescribed plans of care. A policy's operative terms, applicable state law, and tax status must be read together. Certification of eligibility for a tax-qualified contract is not identical to a medical diagnosis, and a consumer's preference for home-based support does not alone satisfy an insurance benefit trigger.

Federal section 4980C issuer requirements regulate certain insurer responsibilities and disclosure in qualified policies, including denial explanations in specified circumstances. The historically incorporated NAIC model versions in federal law are identified by statute; subsequent revisions to a model document do not silently amend the federal cross-reference. For a research reconstruction, the temporal sequence matters: obtain the federal statute as of the relevant decision date, the state enactment, the approved contract form, and any later rider or endorsement.

Who bears which risk

The insured bears any uncovered cost above a daily or total benefit limit, costs during the elimination period, excluded providers or services, and the possibility of remaining underinsured after care costs outpace benefit increases. Under a guaranteed-renewable policy the insurer's obligations and premium-adjustment powers are governed by the actual wording and state regulation; guaranteed renewability generally does not mean a permanently fixed premium. The insurer bears claims arising under covered triggers and remains responsible for contract administration, actuarial reserves, and statutory compliance. Regulators supervise solvency, rates, conduct, and dispute processes within their powers. Informal caregivers may supply hours of unpaid support that alter effective demand for formal services. A salesperson can affect the purchaser's expectations and choices, particularly where commissions or replacement incentives enter the process.

These separate exposures explain why a transaction can appear economical in a brochure but become disadvantageous in later conditions. A nominal benefit amount lacks its full meaning until the contract's duration, location, care type, required proofs, and potential premium trajectory are specified. Suitability should be analyzed as congruence between a household's objectives and these conditional outcomes. The aim is an empirical and documentary test of congruence, not a claim that one insurance contract is universally optimal.

International product boundaries

The European Union's Insurance Distribution Directive generally requires distributors to identify customer demands and needs and give comprehensible objective information before sale. Article 20 distinguishes the demands-and-needs obligation from personalized recommendations where advice is provided; additional suitability regimes for insurance-based investment products have their own scope. Product designers must also examine intended target markets under Article 25 and the related delegated product-governance regulation. A long-term care rider can be attached to different underlying insurance forms, and its classification must be established before applying an investment-product disclosure rule.

In the United Kingdom, the ICOBS 5.2 demands-and-needs rules explicitly apply to distribution processes, including non-advised sales. The ICOBS 6 product-information provisions allocate information-production and delivery responsibilities between insurers and intermediaries. Their current wording was checked in November 2026, while individual obligations retain dates and product classifications shown in the rulebook. Regulatory comparisons should not merge the U.S. NAIC suitability worksheet, the EU demands-and-needs assessment, and investment advice suitability into an imaginary uniform legal test.

Germany offers another useful comparison because voluntary care supplements operate beside mandatory long-term care insurance. The Federal Ministry of Health's guidance on supplementary care insurance distinguishes care-cost reimbursement, fixed daily/monthly allowances, and care pensions. It also describes state-supported supplementary cover requiring, among other conditions, a minimum private contribution of EUR 10 a month and granting EUR 5 a month of public subsidy. Subsidized product eligibility restrictions, benefit schedules and absence of ordinary risk underwriting are central product attributes. A direct premium comparison with U.S. standalone insurance would ignore different compulsory foundations and benefit institutions.

Coverage Exclusions, Benefit Architecture, and Inflation Illustrations

Reading a policy in the order a claim occurs

A consumer information document can list many benefits while failing to make the claim path transparent. A more analytically useful reading follows the order of events. First the insured develops a condition or care need. Second a licensed professional or contracted assessor documents a specified functional deficit or cognitive impairment. Third the insurer evaluates the benefit trigger and any care-plan requirement. Fourth services must fall within the permitted setting, provider category, and contractual definition. Fifth the elimination or waiting period must be satisfied. Sixth eligible reimbursements or indemnities are paid up to the applicable daily or monthly maximum and remaining aggregate pool. Seventh ongoing eligibility and documentation rules apply. Eighth the claim may be interrupted by exhaustion of benefits, recovery, a change in care arrangement, or policy termination.

The NAIC Model Regulation's benefit-trigger provisions provide comparative safeguards concerning assessments and benefit claims, with further provisions on appealing determinations and clean-claim payments. Forensic policy comparison must retain precise wording from the approved form. A high-level description of "home care covered" leaves questions about family-paid caregivers, agency licensure, nurse supervision, informal support, personal assistance, respite, and geographic limitations. The consumer should be able to reconstruct whether a contemplated provider is eligible and what proof would be required.

An exclusion can operate through an explicit list, through a restrictive coverage definition, or indirectly through an unmet trigger. For disclosure purposes these mechanisms should be separated. Exclusions may be stated for particular circumstances; limits may set a payment maximum; conditions precedent may require certification or documentation; a waiting period shifts early care costs to the household. The economic consequence can be similar while the legal source and possibility of appeal differ. Policy comparison requires all four categories and the effective policy edition.

Renewability, premium uncertainty, and replacement

The NAIC model disclosure provisions call for renewability wording and, where appropriate, a statement that rates may change. The same model's rating-disclosure provisions address earlier increases on policy forms, the possibility of future rate revisions, and premium-change notice. Model Regulation section 23 addresses fair marketing, excessive insurance, identification of existing coverage, and auditable sales controls. Model Regulation section 24 adds a suitability assessment for its defined product scope.

A buyer should distinguish initial premium, current premium, projected future premium, a guaranteed premium if any, and the legal conditions for a classwide increase. An illustration stating that a policy is "guaranteed renewable" alongside a premium schedule can be understood as a promise of stable payment unless the changeability of premium is explained in equally visible terms. The technical correction is to show the premium change right, the locus of regulatory approval, historical policy-form experience, and available choices at a proposed increase.

Replacement creates a second set of risks. Age at issue, current health, new underwriting, new definitions, waiting periods, older policy inflation features, and the remaining pool of benefits can make a newer contract less advantageous even if its headline premium is lower. The model replacement safeguards and notices stress comparing existing and proposed coverage and preserving qualifying prior waiting-period credit under specified provisions. A proper comparison keeps both policies in force until lawful replacement conditions are established and evaluates benefits already accumulated; whether that advice is legally required in a particular jurisdiction depends on the applicable enactment and contract.

Inflation protection as an economic variable

An inflation election is a promise about the nominal trajectory of the benefit, not a guarantee that future care is affordable. Let B0 be the initial daily maximum, g the annual compounded benefit increase, C0 an initial daily care cost, c an assumed annual increase in that care cost, and t the elapsed number of years. Ignoring claim eligibility and other limits for illustration:

B(t)=B0(1+g)t,C(t)=C0(1+c)tB(t)=B_0(1+g)^t,\qquad C(t)=C_0(1+c)^t

A preliminary benefit-to-cost ratio is:

Q(t)=B0C0(1+g1+c)tQ(t)=\frac{B_0}{C_0}\left(\frac{1+g}{1+c}\right)^t

This ratio is a conceptual comparison of two price paths. Actual reimbursement cannot exceed eligible expenses, benefits depend on the contract, and care costs vary by region and service. With an annual simple rather than compound increase, the benefit path must be written differently; using one formula for every option would misstate product terms.

For a transparent hypothetical illustration, take a starting maximum benefit of $180 per day, starting comparable eligible care cost of $220 per day, and a 25-year horizon. The following results are arithmetic consequences of the stated assumptions, without an empirical claim about future care inflation:

Annual benefit escalation Annual care-cost escalation Daily benefit after 25 years Daily care cost after 25 years Benefit divided by care cost
0% 3.5% $180.00 $519.91 34.6%
3% compounded 3.5% $376.88 $519.91 72.5%
5% compounded 3.5% $609.54 $519.91 117.2%
0% 5% $180.00 $745.00 24.2%
3% compounded 5% $376.88 $745.00 50.6%
5% compounded 5% $609.54 $745.00 81.8%

The value above 100% in the table represents unused nominal benefit capacity, not payment above incurred eligible costs under a reimbursement contract. All calculations retain unrounded annual compounding and round only displayed outputs. An aggregate lifetime benefit pool or fixed benefit duration could bind before the displayed daily maximum does. The comparison also deliberately excludes premium differences between inflation riders. A purchaser who focuses only on year-one premium may select a materially different distribution of future protection.

The NAIC inflation-protection model provisions require an offer and prescribed disclosure of certain inflation options and allow a documented rejection under specified conditions. The existence of a signed rejection documents a choice; it does not measure whether the purchaser correctly forecast the implied future coverage ratio. Consumer-testing protocols should ask participants to estimate future benefits under several cost scenarios rather than merely to locate the rejection sentence.

Illustration quality and the danger of single-path forecasts

An adequate benefit illustration states the initial benefit, indexation formula, escalation start and end rules, benefit pool, elimination period, illustrative costs, price-path assumptions, and premium implications of each election. It also distinguishes contractually guaranteed values from hypothetical projections. A single smooth graph at one selected annual care-cost growth rate is a scenario, not a probability distribution. A second graph with no inflation and a third with a different rider can make the trade-off visible; a state-neutral minimum presentation should still distinguish any jurisdiction-specific legal requirements.

A useful controlled contrast presents the same contract in three ways: (a) the legal outline alone; (b) the outline plus a benefit/cost path; and (c) both plus an explanation of rate-increase and reduced-benefit choices. Researchers can then assess understanding by asking respondents to derive the amount payable for home care beginning after a specified period, the impact of doubling nominal care prices, and the option remaining after a classwide premium increase. The outcome is objective comprehension, not the respondent's satisfaction with the brochure.

Consumer Understanding, Sales Processes, and Suitability

The economic meaning of a suitable sale

Suitability is an assessment of product-purpose fit under observable information at a decision point. A purchaser may want to protect assets for a spouse, reduce reliance on relatives, fund paid home care, preserve a preferred residence, or limit unpredictable institutional expense. These distinct goals imply different preferred benefits and retention constraints. The NAIC personal worksheet and suitability provisions explicitly consider ability to pay, the purchaser's goals and needs, and the relative value of existing insurance. The model instructs issuers to train agents, use suitability standards, and keep records.

A robust examination distinguishes four operational questions. What financial shock is the household seeking to insure? How much of that shock would the policy actually pay under plausible care scenarios? What premium path could the household sustain after retirement? What alternative allocation of household resources is sacrificed by buying this product? The suitable answer may be a policy, a smaller benefit, a different form of care funding, or no purchase. This is a practical decision audit rather than a prescriptive suitability algorithm or newly proposed insurance doctrine.

Evidence of affordability must reflect income stability and competing essential expenditure, not only net wealth at the application date. A household with liquid assets but unpredictable income may retain a lower-premium product more reliably than a large one; another household may reasonably prefer self-funding. Suitability assessment should describe the existing public-care base, informal support, and contingency plans under conditions where a caregiver becomes unavailable. The NAIC consumer guidance already emphasizes the purchaser's resources, goals, health, existing options and comparative product features.

A critical scope qualification arises with hybrid contracts. Model Regulation section 24 expressly states that its suitability section does not apply to life policies accelerating benefits for long-term care. Accordingly, the mere presence of a long-term care feature does not imply applicability of that model's worksheet. Other insurance, annuity, life illustration, producer, or jurisdiction-specific duties may apply. The legal classification must be tested against exact forms before a compliance judgment is made. A comparison that silently treats all hybrid and standalone products as identically regulated would overstate consumer safeguards.

Multiple sources of low demand

Brown and Finkelstein's (2007) historical policy-price analysis identifies substantial markups relative to expected discounted benefits and limited coverage among typical contracts sold in their observed U.S. market. Their evidence also shows that the availability of more comprehensive contracts does not by itself explain low take-up. Historical loads are not contemporary quotation benchmarks: they depend on issue ages, cohort, persistency assumptions, discounting and public programs.

Finkelstein and McGarry's (2006) multiple-private-information study demonstrates that high underlying risk and preference for insurance can produce opposing selection patterns. A simple observed correlation between insurance and care use is insufficient to infer that the market is free of asymmetric information. This matters for suitability because the buyer's subjective risk and desire for peace of mind may be distinct; neither should be inferred mechanically from age or disease prevalence alone.

In a survey study, Brown, Goda, and McGarry (2012) connect insurance demand to personal beliefs, liquid or other resources, family care expectations, confidence in insurers, and the cost of coverage. Their survey is evidence of multiple associated determinants of demand, not randomized proof that increasing a particular disclosure paragraph will cause new purchases. Boyer and coauthors (2020) use a stated-choice experiment in information frictions and selection, finding substantial information frictions and predicting lower equilibrium take-up and welfare losses in their modeled setting. The experimental design improves identification of price responses to stated alternatives, while extrapolation to an actual sale decades before a claim still requires validation.

The scientific implication is precise. Low purchase rates cannot be treated as direct evidence of uninformed consumers, and high purchase rates cannot establish good sales conduct. Price, Medicaid, available assets, family assistance, product trust, preference, and private risk information may operate simultaneously. A disclosure intervention should be assessed on independently measured understanding and later product outcomes, allowing for this multiplicity.

Sales communication, framing, and informed consent

The legal outline, salesperson explanation, premium quote, advertising, underwriting questionnaire, and completed signed application are separate information channels. Each can alter what the consumer believes the contract promises. A marketing brochure may emphasize "stay at home" while the policy defines eligible home-care providers narrowly; a suitability questionnaire may capture income but ignore future retirement obligations; a premium illustration may present guaranteed renewability more prominently than rate revision rights.

Under the EU Article 20 demands-and-needs obligation, a proposed contract must correspond to the information derived from the customer's requirements, and personalized advice requires an explanation of why the recommendation fits. Under the U.K. ICOBS demands-and-needs process, the obligation survives in non-advised distribution. The FCA product-information framework calls for information delivered in time and understandable in light of complexity. These obligations demonstrate that a sale can be evaluated for the relationship between elicited needs and proposed coverage, even before a claim exists.

For long-horizon care cover, meaningful consent requires a buyer to answer concrete transfer questions. Can benefits pay a licensed home-care agency where the customer expects to live? Who certifies cognitive impairment? Is a stated amount monthly, daily, or a lifetime pool? If care starts in 25 years, what does the chosen inflation option do? What happens if premiums increase and the customer cannot pay? What is lost by replacing an old policy? If the consumer cannot answer these after receiving the material, the communication has an unresolved comprehension problem regardless of how many signed pages have been retained.

The choice environment also matters. The order of alternatives, color, default enrollment, use of frightening narratives, and commission incentives can influence consumer choices. Any test should distinguish a hypothesized framing effect from one demonstrated experimentally in that particular product. The documents considered here establish reasons for scrutiny and methods for testing, rather than a universal numerical framing effect.

Distribution governance and suitability over time

A suitable sale may become misaligned with a consumer's needs after household change or contract revision. The EU product oversight rules require manufacturers and distributors to monitor target-market consistency and respond to significant product developments. This is a general product-governance obligation within its legal scope, not a guarantee that every individual existing contract will be redesigned.

In the U.K., the FCA's TR24/2 thematic review examines oversight and fair value among 28 manufacturers and 39 distributors across ten general or pure-protection product categories. The finding has value as a supervisory warning about product-governance processes, while its reported sample is not an estimate of long-term care insurer misconduct. General conduct findings should be applied to voluntary care insurance as questions to test, not relabeled as direct LTC evidence.

German supplementary care insurance illustrates another dimension of fit: whether a product complements defined public entitlements or attempts to cover an entire unfunded expense. The German government description of care supplements distinguishes cost reimbursement, allowance and care pension. Suitability analysis therefore identifies what compulsory benefits already exist, what expenses remain, and whether cash or reimbursement would serve the policyholder's preferred care arrangement.

Market Conduct, Premium Revisions, and Lapse Risk

The policyholder's second purchase decision

A large premium increase can turn a policyholder's renewal into a decision materially different from the original purchase. The insured has already paid many years of premiums, may have accumulated inflation-indexed benefits, and may now be older or medically ineligible for an equivalent new policy. The available alternatives can include paying the revised premium, reducing the daily benefit, reducing the benefit duration or pool, changing the inflation rider, increasing the elimination period, invoking a nonforfeiture or contingent-benefit option where available, or allowing lapse. These alternatives are not economically equivalent and must be described by the real benefits preserved.

The NAIC's reduced-benefit communication principles recommend balanced presentation, accessible contacts, prominence for the option of maintaining current benefits, avoidance of misleading emphasis, and enough detail to decide without supplementary web material. The guidance is advisory; legal requirements turn on state enactment and applicable orders. The more recent multistate rate-review framework addresses actuarial coordination and was amended in 2025, while individual states retain relevant powers.

The policyholder's problem has three dimensions. First, the revised premium may be unaffordable. Second, benefits relinquished today could be particularly valuable if serious care need begins years later. Third, insurers and regulators may reasonably need sufficient future premiums to meet obligations to the whole block. A communication that explains only the premium increase without the insurance protection surrendered leaves out the core trade-off. Equally, a communication that frames every benefit reduction as irrational ignores household cash constraints.

A transparent hypothetical rate-increase comparison

Consider an illustrative policy with an annual premium of $3,000 and an insurer-announced increase of 52%, bringing the premium to $4,560. Assume that maintaining the contract preserves a $180 daily benefit with a specified inflation feature, and that a fictional reduced-benefit offer would allow a lower future premium in exchange for abandoning future benefit escalation. These numbers are invented only to demonstrate disclosure; they are not extracted from any actual rate filing.

If benefit escalation of 3% had continued for 25 future years, the illustrative $180 daily maximum would become $376.88. Freezing that maximum at $180 means the year-25 daily maximum is lower by $196.88, before considering present value, eligible expenses, premiums, or an aggregate pool. Under assumed care costs of $519.91 per day, the nominal benefit ratio differs from approximately 72.5% to 34.6%. The size of this trade-off depends on the contract's escalation start, prior accumulated increases, rider wording, and whether the offer preserves the current escalated amount. Regulatory communications should show the actual effective benefit path for that offer, not automatically substitute these assumptions.

A decision aid can compare options under at least a low, central, and high care-cost path; identify the amount and timing of premium relief; and state what remains payable under a plausible three-year care claim. The analysis must include lapse rights and the possible value of nonforfeiture. A cash buyout, if offered, also has potential tax and legal consequences that should be identified without assuming uniform treatment. The NAIC-hosted 2026 consumer advocacy policy brief raises precisely these concerns for legacy-policyholders. It is a brief by Bonnie Burns of California Health Advocates contained in meeting materials, rather than a statutory rule or an adopted NAIC actuarial conclusion.

Evidence on policyholder decisions

Noel and Kronlokken's (2025) 2024 U.S. carrier rate survey reports responses from 17 carriers representing more than 75% of U.S. long-term care premiums. The reported average requested increase was 56%, and the reported average approved increase 28% across surveyed submissions; 11.9% of policyholders elected reduced-benefit options and 2% selected contingent benefit upon lapse. These are survey-defined statistics and do not establish that every market or vintage has these rates. The population of submitted rate actions differs from the population of all insured lives, and the timing of consumer elections requires caution.

A qualitative investigation of financial planners examines how advisers perceive the complexity of rate-change and benefit-reduction choices. Such interviews can reveal decision mechanisms and overlooked explanation needs. They cannot on their own identify the causal effect of an individual letter template on policyholder lapse. Evidence hierarchies matter: a survey of insurers, a planner interview, an administrative lapse record, and a randomized communication test answer different questions.

A separate state-level operational illustration is the Virginia Bureau of Insurance's policyholder communications checklist. It asks whether premium-change communications include clear decision deadlines, current benefit comparisons, available options, and warnings about limited periods or retained benefit amounts. The checklist demonstrates how broad consumer-protection objectives can become auditable fields. It is a state supervisory artifact with its own effective context, not an international compliance obligation.

Voluntary lapse, unintended lapse, and contingent protection

Lapse is a label for heterogeneous processes. A person may voluntarily stop buying coverage after revising expectations; a person may become unable to meet premiums; a direct debit may fail; cognitive impairment may prevent bill payment; a contract may terminate under specific conditions. The welfare implications differ. An observed lapse following a premium increase may reflect financial distress, a well-informed choice, misunderstanding of future benefits, or unintentional nonpayment. Individual-level data are required to distinguish them.

NAIC Model Regulation section 7 on unintended lapse proposes advance notice to a designated third party or a signed waiver and a reinstatement route where cognitive impairment or functional loss caused nonpayment, subject to specified conditions. Section 28 addresses nonforfeiture and contingent benefits for its covered forms. These safeguards have a distinctive consumer-protection logic: the condition against which insurance is intended to protect may also impair the insured's ability to keep the policy administratively active.

The NAIC model also requires reporting about agents with unusual replacement and lapse patterns. The text expressly warns that such patterns alone do not establish legal wrongdoing. That caution is analytically sound. High lapse or replacement incidence may be a screening signal for review, but robust causal interpretation requires cohort adjustment, initial underwriting, policy age, rate increases, household resources, death, transfers, and coverage changes. A dashboard that ranks agents solely by raw lapse counts can produce false allegations and missed problems.

Claims outcomes and the disclosure feedback loop

The quality of a sale is partly testable only when a claim is made. A claim rejected for an unexpectedly excluded care setting reveals a possible expectation gap, but it does not prove that the initial contract wording was unlawful or that the individual salesperson misrepresented it. Researchers need the edition-specific policy, application, marketing and suitability record, claims correspondence, care invoices, functional assessment, and contemporaneous legal rules. Federal section 4980C denial disclosures and relevant state appeals mechanisms help define the documentary trail.

Claims disputes should be fed back into sales disclosure in a disciplined manner. If many validly denied claims concern the same misunderstood service requirement, an insurer can test whether its outline and script communicated that requirement. If denials concern provider-documentation burdens, improvements may belong in administration rather than in the original sales form. A claims-based inference must adjust for differences in care use and policyholder health across product variants. The ultimate outcome of interest is whether insured financing works under the consumer's reasonably anticipated claim setting.

Source Validation, Causal Identification, and Comparative Method

Evidence unit and temporal control

The primary unit for documentary analysis is an identified policy-form version in an identified jurisdiction at an identified date, linked to a particular sales channel. A model regulation is one evidence object; an enacted state rule is a different object; the insurer's approved form is another. A brochure may summarize policy features but does not supersede a contract. A regulator's guidance may recommend a practice without creating an enforceable rule. The coding record must preserve these distinctions to avoid inflating normative claims.

For a U.S. cohort, the minimum reconstruction includes the state's actual statutes and regulations effective at sale, the insurer's original application and outline, filing and rate history, any inflation-protection rejection, the personal worksheet if applicable, rider and replacement documents, the delivery date, premium-increase notices, current in-force benefit schedule, and claim decision if any. For EU member states, begin with the consolidated Insurance Distribution Directive, identify implementing national measures, then inspect product category and distribution records. For U.K. sales, use the operative version of ICOBS 5.2 and the actual authorization category. For German supplementary cover, retain the underlying statutory care benefit and any subsidy eligibility as of the purchase year.

Scientific literature requires the same date discipline. Brown and Finkelstein (2007) observed policy choices and prices in a historical market. The 2024 carrier survey reported by Noel and Kronlokken (2025) reflects a different market, policy vintage and regulatory setting. Neither should be used as a direct numerical estimate for a new product sold in 2026 without adjustment. The 2024 EIOPA Consumer Trends Report, released in 2025, addresses broad categories of insurance and pension attitudes. Its companion Eurobarometer survey comprises 25,951 interviews with EU adults; those respondents do not represent a purpose-built sample of private long-term care insurance buyers. These distinctions prevent false transfer of empirical claims.

Reproducible document analysis

An individual research record should store: document title; issuer; date and effective period; jurisdiction; policy form or directive number; source URL; relevant page or section; exact observed wording; legal status; consumer decision affected; researcher interpretation; and any unresolved contradiction. Versioned archive copies are desirable when terms change. A link to a living institutional page is useful for access but weaker evidence of what a consumer saw twenty years earlier than a contemporaneous contract or archived filing.

A disclosure comparison can code whether a source makes each of the following reconstructable: eligibility definition; qualifying care settings and providers; exclusions; elimination period; periodic and total maximum; inflation formula; premium increase right; past rate increases on the relevant form; lapse warning; reinstatement or nonforfeiture rights; replacement risk; complaint or appeal route; and costs after public benefit coordination. Code availability of the information separately from comprehension. Presence is a documentary variable; comprehension is a human outcome; legal compliance is a jurisdiction-specific judgment.

For external reproducibility, investigators should predeclare a coding guide, train at least two independent reviewers, publish an adjudication log for disagreements, and report inter-rater agreement appropriate to the distribution of coded categories. Agreement does not validate a legal interpretation by itself. Where data come from insurers, analyze nonresponse, omitted failed applicants, unobserved contracts, and the limits of personally identifiable data. A research archive must minimize and protect sensitive financial and functional-health records.

Identification of information effects

The simplest study compares comprehension before and after a revised disclosure. Such a design is susceptible to learning, selection and time effects. A stronger randomized experiment varies presentation across substantively identical contracts while holding price and benefits constant. Eligible outcomes include correctly identifying the triggering activities of daily living, estimating future benefit-to-cost ratios, recognizing classwide premium-change rights, distinguishing unintentional from chosen lapse, and understanding the value surrendered in a reduced-benefit election. Randomization can identify a local effect of the communication format in the trial population if implemented and analyzed correctly. It cannot guarantee long-term claims outcomes.

In an observational sales study, let Y denote later lapse or benefit reduction, D exposure to a specific sales/disclosure process, and X measured confounders such as age, health, issue vintage, state, insurer, premiums, household finances and channel. A regression of Y on D and X yields a conditional association. Calling it the causal effect of disclosure requires credible assumptions about residual confounding, timing, attrition and interference. Instrumental variables, staggered regulatory reforms, or difference-in-differences may be informative only where exclusion restrictions or parallel trends are defended with institutional evidence and falsification checks. The present monograph does not estimate such a model.

Claims and retention data create additional hazards. Death competes with lapse and claim. Selection into surviving in-force policies can bias comprehension comparisons. Renewal choices observed after a premium increase are conditional on having remained insured and on insurer decisions about rate filing. Claims-denial rates require consistent denominators and treatment of incomplete documentation and waiting-period cases. An unadjusted low lapse rate can reflect strong perceived value, adverse risk selection, or sunk-cost concerns. A high lapse rate can reflect unsuitable sales, premium shocks, or changing household priorities. Each hypothesized mechanism needs a measurable discriminating test.

Legal comparison as a structured matrix

Analytical question United States reference EU framework United Kingdom application Germany supplementary setting
Initial needs and suitability State-adopted LTC rules; NAIC Model Regulation section 24 within its scope IDD Article 20 demands and needs ICOBS 5.2 plus applicable advice rules Product- and distribution-specific law alongside compulsory care coverage
Core product information State policy forms and NAIC outlines; federal tax-qualified requirements IDD precontractual information, with form-specific requirements ICOBS 6 and product category Supplementary insurance terms and any subsidy conditions
Product governance Insurer/state conduct and filing supervision IDD Article 25 and Regulation 2017/2358 FCA governance and Consumer Duty within scope National supervision and supplementary product conditions
Premium change and continuity Contract/state rate review; third-party lapse notices where adopted Contract and national insurance-law controls Contract and FCA conduct requirements Contract, underlying compulsory insurance and specific policy obligations
Source needed for a legal judgment Enacted state rule, approved policy form and date Implementing national rule, product classification and date Effective FCA rule, permissions and contract German legislation, exact tariff and subsidy eligibility

This table maps research questions; it does not purport to certify compliance of a hypothetical insurance contract in any jurisdiction. The NAIC model and the federal statute are not interchangeable. The EU directive is implemented within national systems. FCA rules apply according to product and regulated activity. German subsidies have separate statutory conditions. A comparative table that ignores these distinctions would create only superficial international coverage.

Sensitivity and the limits of the present evidence

A complete empirical study should report sensitivity to inflation assumptions, date of first care need, paid versus informal care substitution, regional care-cost dispersion, mortality, policy lapse, contract amendments, interest-rate scenarios, insurer insolvency, and changes in government entitlements. Illustration calculations should include the cost of the rider and demonstrate the difference between nominal benefits and effective claims payments after policy limits. A stochastic model would require calibrated parameters; presenting one deterministic scenario as an actuarial forecast would be an error.

For clarity about source access, the research used official HTML codifications and extracted original regulatory documents, journal publisher records and abstracts, one author-hosted scholarly text, and regulator or publisher summaries. The NAIC PDFs were available as textual search extraction, while attempted graphical PDF screenshot retrieval returned cache errors. Several journal findings were checked at their official publisher abstract rather than through unrestricted full-text inspection. No confidential insurer forms, proprietary claims datasets, representative household interviews, or independent legal opinions were obtained for this study. These limitations constrain claims of completeness and prohibit presenting the illustrative scenarios as empirical market findings.

Integrated Analysis and Research Agenda

Why disclosure quality must follow the contract's life cycle

The preceding analysis reveals a recurring asymmetry in timing. The original purchaser chooses among potential future benefits while the insurer possesses technical knowledge of product design and pricing. Decades later, a policyholder may have a clearer picture of expected care needs but face a much narrower feasible set of replacement products. Communication quality therefore matters at issuance, at any substantial policy change, at premium revision, and at claim. These are different choice moments with different available actions, financial constraints, and legal disclosures.

An original analytical conclusion follows: a disclosure is decision-relevant when the reader can reconstruct a future financial consequence that could change a reasonable choice. Merely mentioning a risk category is weaker than showing how that risk changes benefits. For example, a notice that "inflation protection is optional" gives less practical information than a compact comparison of future daily caps at several horizons. Likewise, a reduced-benefit letter that lists three options with lower premiums but fails to display the preserved benefit pool does not permit a complete comparison. This is an evaluative conclusion grounded in the contracts, regulatory guidance and economic mechanisms examined here, not a new named theory.

The limits of one-time suitability

Suitability is commonly documented at the point of sale. The buyer's age, income, liquidity, family arrangements and care preferences can change; so can the premium charged on a guaranteed-renewable contract where classwide changes are permitted. Thus an original sale with an accurate worksheet does not exhaust the later consumer-protection problem. Periodic communications at material changes can be tested for whether they reconnect present options to the purpose of the original purchase without substituting the insurer's preferred choice.

The consumer is entitled to a clear distinction between a legally enforceable right, an available discretionary option, and a scenario that has no guaranteed future value. In practice, that distinction is especially important for hybrid products whose death benefit, cash surrender value, accelerated long-term care benefit and extension-of-benefits rider may interact. Unbundling the parts in the explanation can prevent one monetary figure from being counted twice in a consumer's mental arithmetic. The necessary legal check remains product-form-specific.

Risk distribution and the quality of a market decision

Private long-term care insurance transfers a portion of uncertain care expenses to an insurer. It does not remove the need for public programs, family care, available providers, or the household's financial planning. The value of this transfer depends on the correlation between care need and liquid resources, the policy's claim conditions, and confidence that the insurer can perform under a long-lived promise. A policy with higher nominal benefits but more restrictive provider eligibility may serve a different goal than a lower-limit cash-indemnity policy. A suitable sale identifies the goal before ranking the contracts.

The empirical literature supports this plural interpretation. Brown and Finkelstein's market-size analysis points to both prices and demand-side mechanisms; Brown, Goda, and McGarry's household survey documents the association of expectations, families and trust with ownership; Boyer and colleagues' stated-choice evidence specifically examines information frictions. The studies differ in time, sampling and outcome. Together they justify testing the informational quality of insurance offers as one contributor to market behavior rather than assuming that better brochures alone solve low insurance take-up.

Directions for further research

A priority research design would join state insurance rate filings to policy-form version, household-level retention data, and copies of the actual reduced-benefit communication. It would compare comparable cohorts receiving different but lawful notice formats and measure comprehension, option choice, later paid claims, grievances and reinstatement. Privacy-preserving linkage and transparent missingness analysis are essential. The causal effect of a communication change can be estimated most convincingly where its timing or assignment is plausibly external to consumer risk.

A second design would experimentally compare future-benefit illustrations using identical prices and legal coverage, varying only the expression of inflation, benefit pools, and premium uncertainty. Separate experiments should test buyers approaching retirement and existing policyholders receiving a real rate notice; their decisions are structurally different. Comprehension questions should require calculations and application to care settings, not subjective ratings of clarity. Pre-registered outcomes, accessible materials and subgroup analyses for literacy or cognitive accessibility would improve interpretability.

A third comparative project would examine whether EU and U.K. demands-and-needs records correspond to actual contracted care outcomes, while distinguishing statutory programs from voluntary supplements. The cross-country question is whether regulators obtain enough information to audit product-purpose fit, rather than whether identical documents appear in every market. For Germany, the interplay of compulsory benefits, subsidized top-ups and different payment structures would be central. For U.S. states, tax qualification, NAIC model adoption, policy vintage and premium approval would be coded separately.

The results of these studies could inform regulator-specific disclosure tests, but the current record supports no universal numerical threshold for affordability, ideal inflation rider, optimal benefit period, or acceptable policyholder lapse rate. Such thresholds depend on local prices, product obligations, household preferences, and empirical distributions that are not established in this monograph.

Conclusion

Long-term care insurance consumer protection is an intertemporal contractual and distribution problem. The original sales decision allocates a share of future care risk among insurer, insured household, relatives and public programs. That allocation can change materially when care prices rise, a premium increase is approved, the insured's health changes, a rider is replaced, or a claim reveals a misunderstood eligibility condition.

Primary U.S. instruments provide detailed examples of disclosure, suitability, inflation, replacement and lapse protections. Their legal meaning depends on actual state adoption and policy form; federal tax-qualified provisions have distinct statutory boundaries. European Union and U.K. rules emphasize comprehensible information, customer demands and needs, and appropriate governance, while German supplementary insurance operates against a different mandatory-care financing base. Comparisons become scientifically valid when those legal and institutional boundaries are preserved.

The independent synthesis supports three conclusions. First, substantive disclosure should permit reconstruction of the contract's financial consequence, not merely identify benefit labels. Second, suitable distribution requires matching coverage with household goals and sustainable retention capacity while identifying what public and informal support the household expects. Third, lapse and reduced-benefit elections are informative outcomes only when their causes and competing risks are investigated. A premium-shock event warrants a renewed disclosure of preserved benefits and forfeited protection because the consumer's choice set has changed.

The deterministic benefit scenarios show the magnitude of possible nominal erosion under stated assumptions; they are arithmetic demonstrations, not market forecasts. The legal and academic sources establish a research basis for more precise communication and empirical tests, while source-access and causal limits remain documented. Future progress will be measured by whether consumers can understand, maintain, and realize the protection they actually purchased. This conclusion is an original evidence-based analysis and makes no claim to a new authored insurance theory.

References

  • National Association of Insurance Commissioners (2017). Long-Term Care Insurance Model Act (MO-640). model legal instrument. Source text.

  • National Association of Insurance Commissioners (2017). Long-Term Care Insurance Model Regulation (MO-641). model legal instrument. Source text.

  • National Association of Insurance Commissioners (2022). A Shopper's Guide to Long-Term Care Insurance. official consumer guide. Source text.

  • National Association of Insurance Commissioners (n.d.). Long-Term Care Insurance: Consumer Guide. official regulatory consumer guidance. Source text.

  • National Association of Insurance Commissioners (n.d.). Insurance Topics: Long-Term Care Insurance. regulatory institutional overview. Source text.

  • National Association of Insurance Commissioners (2020). Communication Principles for Long-Term Care Insurance Reduced Benefit Options. regulatory guidance. Source text.

  • National Association of Insurance Commissioners (2025). Long-Term Care Insurance Multistate Rate Review Framework. regulatory framework. Source text.

  • National Association of Insurance Commissioners (n.d.). Long-Term Care Insurance Multistate Rate Review. institutional program. Source text.

  • United States Congress (2026). 26 U.S.C. section 7702B, Treatment of Qualified Long-Term Care Insurance. U.S. federal primary law. Source text.

  • United States Congress (2026). 26 U.S.C. section 4980C, Requirements for Issuers of Qualified Long-Term Care Insurance Contracts. U.S. federal primary law. Source text.

  • Centers for Medicare & Medicaid Services (n.d.). Medicare Coverage: Long-Term Care. public program primary guidance. Source text.

  • Centers for Medicare & Medicaid Services (n.d.). Home & Community-Based Services 1915(c). public program primary guidance. Source text.

  • European Parliament and Council (2016, consolidated 2024). Directive (EU) 2016/97 on Insurance Distribution. EU primary law. Source text.

  • European Commission (2017). Commission Delegated Regulation (EU) 2017/2358 on Insurance Product Oversight and Governance. EU primary law. Source text.

  • Financial Conduct Authority (2026). Insurance Conduct of Business Sourcebook: ICOBS 5.2 Demands and Needs. UK rulebook. Source text.

  • Financial Conduct Authority (2026). Insurance Conduct of Business Sourcebook: ICOBS 6 Product Information. UK rulebook. Source text.

  • Financial Conduct Authority (2024, updated 2025). TR24/2: General Insurance and Pure Protection Product Governance Thematic Review. official supervisory research. Source text.

  • Federal Ministry of Health, Germany (2026). Die Versicherten: Pflegeversicherung und private Pflege-Zusatzversicherung. German government guidance. Source text.

  • Brown, Jeffrey R., and Amy Finkelstein (2007). Why Is the Market for Long-Term Care Insurance So Small?. peer-reviewed study. Source text.

  • Finkelstein, Amy, and Kathleen McGarry (2006). Multiple Dimensions of Private Information: Evidence from the Long-Term Care Insurance Market. peer-reviewed study. Source text.

  • Brown, Jeffrey R., Gopi Shah Goda, and Kathleen McGarry (2012). Long-Term Care Insurance Demand Limited by Beliefs About Needs, Concerns About Insurers, and Care Available from Family. peer-reviewed study. Source text.

  • Boyer, M. Martin, Philippe De Donder, Claude Fluet, Marie-Louise Leroux, and Pierre-Carl Michaud (2020). Long-Term Care Insurance: Information Frictions and Selection. peer-reviewed study. Source text.

  • Noel, Cassi, and Courtney Kronlokken (2025). LTC Rate Increase Landscape Update. industry actuarial survey. Source text.

  • National Association of Insurance Commissioners (2026). Insurance Products and Paying for Long-Term Care: Consumer Liaison Supplemental Materials. consumer advocacy briefing hosted in regulatory meeting materials. Source text.

  • Virginia State Corporation Commission, Bureau of Insurance (2024). Long-Term Care Insurance Policyholder Communications Checklist. state regulatory checklist. Source text.

  • European Insurance and Occupational Pensions Authority (2025). Consumer Trends Report 2024. supranational consumer research. Source text.

  • European Insurance and Occupational Pensions Authority (2025). Eurobarometer 2024: Consumer Trends in Insurance and Pension Services. supranational survey. Source text.

  • Delaware Department of Insurance / NAIC Research (2022). Long-Term Care Insurance Rate Increases and Reduced Benefit Options: Insights from Interviews with Financial Planners. qualitative study. Source text.